Publication: 89 Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
No Thumbnail Available
Open/View Files
Date
2011
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
American Chemical Society
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Keliher, Edmund J., Jeongsoo Yoo, Matthias Nahrendorf, Jason S. Lewis, Brett Marinelli, Andita Newton, Mikael J. Pittet, and Ralph Weissleder. 2011. “89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging.” Bioconjugate Chemistry 22 (12): 2383–89. https://doi.org/10.1021/bc200405d.
Research Data
Abstract
Tissue macrophages play a critical role both in normal physiology and in disease states. However, because of a lack of specific imaging agents, we continue to have a poor understanding of their absolute numbers, flux rates, and functional states in different tissues. Here, we describe a new macrophage specific positron emission tomography imaging agent, labeled with zirconium-89 (Zr-89), that was based on a cross-linked, short chain dextran nanoparticle (13 nm). Following systemic administration, the particle demonstrated a vascular half-life of 3.9 h and was found to be located primarily in tissue resident macrophages rather than other white blood cells. Subsequent imaging of the probe using a xenograft mouse model of cancer allowed for quantitation of tumor-associated macrophage numbers, which are of major interest in emerging molecular targeting strategies. It is likely that the material described, which allows the visualization of macrophage biology in vivo, will likewise be useful for a multitude of human applications.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service